| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |